Chang‐Ki Min
- Hematology top 2%
- Multiple Myeloma Research and Treatments 23
- Hematopoietic Stem Cell Transplantation 16
- Oncology top 10%
- Peptidase Inhibition and Analysis 10
- Cancer Treatment and Pharmacology 3
- Genetics top 10%
-
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4
- Spectroscopy top 10%
-
- Protein Degradation and Inhibitors 8
- Co-authors
- Shawn G. ClouthierJames L.M. FerraraSeok LeeUlrich DuffnerHong WangGilbert S. OmennDavid E. MisekRong Zhao
- Cited by
- HematologyOncologyGenetics
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Chang‐Ki Min
41 papers receiving 683 citations
Peers
Comparison fields: 5 of 74
- Hematology 430
- Oncology 251
- Genetics 83
- Immunology 163
- Spectroscopy 71
Countries citing papers authored by Chang‐Ki Min
This map shows the geographic impact of Chang‐Ki Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Ki Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Ki Min more than expected).
Fields of papers citing papers by Chang‐Ki Min
This network shows the impact of papers produced by Chang‐Ki Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Ki Min. The network helps show where Chang‐Ki Min may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chang‐Ki Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2019 | 93 | |
| 4 | 2017 | 11 | |
| 5 | 2017 | 28 | |
| 6 | 2016 | 3 | |
| 7 | 2015 | 3 | |
| 8 | 2015 | 19 | |
| 9 | 2015 | 7 | |
| 10 | 2015 | 7 | |
| 11 | 2014 | 3 | |
| 12 | 2014 | 6 | |
| 13 | 2011 | 4 | |
| 14 | 2011 | 7 | |
| 15 | 2010 | 25 | |
| 16 | 2007 | 17 | |
| 17 | 2006 | 35 | |
| 18 | 2006 | 28 | |
| 19 | 2005 | 113 | |
| 20 | 2002 | 15 |
About Chang‐Ki Min
Chang‐Ki Min is a scholar working on Hematology, Oncology and Immunology, having authored 43 papers that have together received 698 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (23 papers), Hematopoietic Stem Cell Transplantation (16 papers), Peptidase Inhibition and Analysis (10 papers), Immune Cell Function and Interaction (8 papers), Protein Degradation and Inhibitors (8 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Hematology (430 citations), Oncology (251 citations) and Genetics (83 citations). Chang‐Ki Min has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Shawn G. Clouthier, James L.M. Ferrara, Seok Lee, Ulrich Duffner, Hong Wang, Gilbert S. Omenn, David E. Misek, Rong Zhao, Samir Hanash and Eun Young Choi. Their work appears in journals such as Nature Communications, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.